Archives: Speakers

Emma Taylor

Emma Taylor is an Associate Analyst in GlobalData’s Thematic Intelligence Team specialising in Machine Learning, AI regulation, and cybersecurity. Before joining GlobalData Emma completed a Master’s degree in ‘Big Data in Culture and Society’ conducting research on data law, algorithmic bias, surveillance and Facial Recognition Technology.

Andrea Bottkova

I currently work as Senior Director of Procurement and Vendor Management at Karyopharm Therapeutics Inc. I have been negotiating contracts for little over fifteen years. Working 10 years in the biotech industry I have gained an excellent Understanding of all areas of research and development. In 2019 I helped establish Karyopharm’ s vendor management and procurement department to support vendor oversight, strategic sourcing maximizing financial savings. I am passionate about building partnerships and negotiating business terms of contracts resulting in several million dollar savings annually. I believe that I have perfected my negotiations skills while learning from my very curious 7-year-old son Barton.

Dana Lee

Dana Lee PharmD, RPh is currently a Senior Scientist within the Biomarker Development group at Novartis Institutes for BioMedical Research (NIBR) in Cambridge, MA. She provides biomarker sample management and support in early phase clinical trials, working in close collaboration with Biomarker Experts and the clinical trial team. Along with her primary role, she is also a member of the Central Lab SME Team along with the Smart Sampling/Testing Task Force within NIBR-TM. Within the Central Lab SME Team, she contributes to leading efforts around process improvement / strategy in Central Lab partnership to enable Novartis clinical trials. Dana received her PharmD degree from Temple University School of Pharmacy in 2020 and Bachelor’s degree in Biology from Clark University.

Jodi Coughlin

Jodi Coughlin, Director of Vendor Relationship Management at Deciphera Pharmaceuticals has over 15 years of industry experience spanning across small to large CRO and Sponsor organizations.  She attributes developing budgets and proposals in her early CRO days to deepening her understanding of the critical relationship between CROs and Sponsors. As she progressed in her career, Jodi transitioned to supporting Sponsor organizations in Outsourcing Management, developing processes and negotiating CRO budgets and contracts for Phase I-IV clinical trials.  Her passion for developing effective communication and governance structures expanded as she discovered a gap in “true strategic partnerships” between cross-functional trial teams.  With the addition of ICH E6 R2, Jodi found her niche as she began to lead and develop strategic and innovative vendor management and performance management oversight solutions between Sponsor and CRO matrix organizations.  She is highly passionate about establishing internal and external cross-functional communication processes and finds joy in building positive strategic partnerships that drive quality performance in support of clinical trial development.

Kathryn Duschean

Dr. Kathryn Duschean is a Senior Scientist in Biomarker Development at Novartis Institutes for Biomedical Research in Cambridge, MA, following a 2-year post-doctoral fellowship. She is currently involved in biomarker operational planning, focusing on streamlining fully outsourced studies containing biomarkers. She is also involved in the implementation, and validation of novel patient-centric sampling techniques across a variety of therapeutic areas. Her deep personal passions and former research in autoimmune and related conditions heavily influence and progress her interests and projects in this area. She believes that engaging with internal and external partners is critical to advancing the capabilities of clinical trials, including recruitment and decentralization. Kathryn received both bachelors in English, and in Health Sciences from the University of Iowa, and her PharmD from the University of Colorado.